Neoadjuvant FOLFIRINOX for Patients with Borderline Resectable or Locally Advanced Pancreatic Cancer: Results of a Decision Analysis.
Choi JG, Nipp RD, Tramontano A, Ali A, Zhan T, Pandharipande P, Dowling EC, Ferrone CR, Hong TS, Schrag D, Fernandez-Del Castillo C, Ryan DP, Kong CY, Hur C.
Choi JG, et al. Among authors: zhan t.
Oncologist. 2019 Jul;24(7):945-954. doi: 10.1634/theoncologist.2018-0114. Epub 2018 Dec 17.
Oncologist. 2019.
PMID: 30559125
Free PMC article.